Cargando…

Association of Brain Metastases With Survival in Patients With Limited or Stable Extracranial Disease: A Systematic Review and Meta-analysis

IMPORTANCE: Intracranial metastatic disease (IMD) is a severe complication of cancer with profound prognostic implications. Patients with IMD in the setting of limited or stable extracranial disease (IMD-SE) may represent a unique and understudied subset of patients with IMD with superior prognosis....

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Alyssa Y., Gaebe, Karolina, Zulfiqar, Amna, Lee, Grace, Jerzak, Katarzyna J., Sahgal, Arjun, Habbous, Steven, Erickson, Anders W., Das, Sunit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951042/ https://www.ncbi.nlm.nih.gov/pubmed/36821113 http://dx.doi.org/10.1001/jamanetworkopen.2023.0475

Ejemplares similares

Incidence and real-world burden of brain metastases from solid tumors and hematologic malignancies in Ontario: a population-based study
por: Habbous, Steven, et al.
Publicado: (2020)

Intracranial Metastatic Disease: Present Challenges, Future Opportunities
por: Li, Alyssa Y., et al.
Publicado: (2022)

HER2-targeted therapy prolongs survival in patients with HER2-positive breast cancer and intracranial metastatic disease: a systematic review and meta-analysis
por: Erickson, Anders W, et al.
Publicado: (2020)

PD-L1 expression in breast cancer brain metastases
por: Chehade, Rania, et al.
Publicado: (2022)

Dual- versus single-agent HER2 inhibition and incidence of intracranial metastatic disease: a systematic review and meta-analysis
por: Erickson, Anders Wilder, et al.
Publicado: (2021)

THER-01. Targeted therapy and intracranial metastatic disease: a population-based retrospective cohort study
por: Erickson, Anders, et al.
Publicado: (2021)

Analysis of Rates of Brain Metastases and Association With Breast Cancer Subtypes in Ontario, Canada
por: Wang, Xin Ye, et al.
Publicado: (2022)

Clinical Biomarkers for Early Identification of Patients with Intracranial Metastatic Disease
por: Gaebe, Karolina, et al.
Publicado: (2021)

Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis
por: Poon, Ian, et al.
Publicado: (2020)

Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases
por: Soliman, Hany, et al.
Publicado: (2016)

Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases
por: Weiss, Sarah A., et al.
Publicado: (2020)

Assessment of Effectiveness and Safety of Osimertinib for Patients With Intracranial Metastatic Disease: A Systematic Review and Meta-analysis
por: Erickson, Anders W., et al.
Publicado: (2020)

Editorial: Contemporary Management of Intracranial Metastatic Disease
por: Das, Sunit, et al.
Publicado: (2019)

Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases
por: Carpenter, David J., et al.
Publicado: (2023)

34. TARGETED THERAPY FOR HER2-POSITIVE BREAST CANCER BRAIN METASTASES: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Erickson, Anders, et al.
Publicado: (2020)

Extracranial metastases of anaplastic meningioma
por: Thomas, Robbin Zachery, et al.
Publicado: (2017)

Commentary: Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
por: Das, Sunit, et al.
Publicado: (2020)

MOLECULAR PROFILING TO UNDERSTAND TREATMENT RESISTANCE AND RESPONSE IN GLIOBLASTOMA
por: Nikolopoulos, Marina, et al.
Publicado: (2023)

The Impact of Targeted Therapy on Intracranial Metastatic Disease Incidence and Survival
por: Erickson, Anders W., et al.
Publicado: (2019)

Paraneoplastic symptoms caused by extracranial meningioma metastases?
por: Mindermann, Thomas
Publicado: (2016)

Extracranial metastases in glioblastoma—Two case stories
por: Schou Nørøxe, Dorte, et al.
Publicado: (2018)

Favorable prognosis of breast cancer brain metastases patients with limited intracranial and extracranial metastatic lesions
por: Shi, Wei, et al.
Publicado: (2023)

TREATMENT, HEALTHCARE UTILIZATION AND OUTCOMES IN PATIENTS WITH GLIOBLASTOMA IN ONTARIO: A 10-YEAR COHORT STUDY
por: Rzadki, Kathryn, et al.
Publicado: (2023)

OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM)
por: Kennedy, Lucy Boyce, et al.
Publicado: (2021)

Progression-Free but No Overall Survival Benefit for Adult Patients with Bevacizumab Therapy for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis
por: Kaka, Nagham, et al.
Publicado: (2019)

Procarbazine, CCNU and vincristine (PCV) versus temozolomide chemotherapy for patients with low-grade glioma: a systematic review
por: Hafazalla, Karim, et al.
Publicado: (2018)

Volumetric burden of metastatic lesions drives outcomes in patients with extracranial oligometastatic disease
por: Cao, Yilin, et al.
Publicado: (2021)

SYST-03 INCIDENCE AND SURVIVAL OF PATIENTS WITH INTRACRANIAL METASTATIC DISEASE AND ERBB2-POSITIVE GASTROINTESTINAL CANCERS: A RETROSPECTIVE COHORT STUDY
por: Sherman, Madison, et al.
Publicado: (2022)

Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases
por: In, Gino K., et al.
Publicado: (2020)

Extracranial metastases of high-grade glioma: the clinical characteristics and mechanism
por: Sun, Qian, et al.
Publicado: (2017)

Extracranial metastases in secondary glioblastoma multiforme: a case report
por: Rossi, Jessica, et al.
Publicado: (2020)

Primary gliosarcoma with widespread extracranial metastases—spatiotemporal morphological variation
por: Luo, Ming, et al.
Publicado: (2022)

Mutational signature of extracranial meningioma metastases and their respective primary tumors
por: Biczok, A., et al.
Publicado: (2023)

CHOREOGRAPHED EXPANSION OF SERVICES RESULTS IN DECREASED PATIENT BURDEN WITHOUT COMPROMISE OF OUTCOMES: AN ASSESSMENT OF THE ONTARIO EXPERIENCE
por: Rzadki, Kathryn, et al.
Publicado: (2023)

Efficacy and Safety of Extracranial Vein Angioplasty in Multiple Sclerosis: A Randomized Clinical Trial
por: Zamboni, Paolo, et al.
Publicado: (2017)

Hypofractionated Stereotactic Radiotherapy in Five Daily Fractions for Post-Operative Surgical Cavities in Brain Metastases Patients with and without Prior Whole Brain Radiation
por: Al-Omair, Ameen, et al.
Publicado: (2013)

Polidocanol Sclerotherapy Combined with Transarterial Embolization Using n-Butyl Cyanoacrylate for Extracranial Arteriovenous Malformations
por: Kitagawa, Akira, et al.
Publicado: (2018)

Rare Case of Extracranial Metastases in a Patient with IDH-Mutant Glioblastoma
por: Thimma Sudarsan, Rishan, et al.
Publicado: (2022)

04. ASSESSMENT OF EFFICACY AND SAFETY OF OSIMERTINIB FOR PATIENTS WITH INTRACRANIAL METASTATIC DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Erickson, Anders, et al.
Publicado: (2020)

Karnofsky Performance Status (KPS) ≤60 Is Strongly Associated With Shorter Brain-Specific Progression-Free Survival Among Patients With Metastatic Breast Cancer With Brain Metastases
por: Freeman, Mark, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8djg5l57rgefspcuupterem0gp